Symbiosis Pharmaceutical expands business development team in US: Stirling, UK Saturday, November 30, 2024, 18:00 Hrs [IST] Symbiosis Pharmaceutical Services, a world-class contra ...
Hutchmed announces continued inclusion of Orpathys in the National Reimbursement Drug List in China at current terms: Hong Kong, Shanghai Saturday, November 30, 2024, 16:00 Hrs [I ...
Praxis Precision Medicines, Inc, a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by ...
Quadria Capital Report reveals USD 3 billion annual investment opportunity in climate-health adaptation for India: Our Bureau, Mumbai Saturday, November 30, 2024, 12:20 Hrs [IST] ...
Zai Lab announces the inclusion of Augtyro for ROS1+ NSCLC and other updates in China’s National Reimbursement Drug List: Shanghai Saturday, November 30, 2024, 13:00 Hrs [IST] Z ...
NIHR launches £25 million funding to decarbonise the health and social care system: United Kingdom Saturday, November 30, 2024, 14:00 Hrs [IST] The NIHR has launched a new £25 m ...
Boehringer Ingelheim introduces Eurican L4 vaccine to protect dogs against leptospirosis: Ingelheim, Germany Saturday, ...
Venlo, the Netherlands Saturday, November 30, 2024, 10:00 Hrs [IST] ...
Entod Pharmaceuticals outperforms market growth in ENT sector: Our Bureau, Mumbai Saturday, November 30, 2024, 12:45 Hrs [IST] Entod Pharmaceuticals, a leader in the eye care sect ...
India takes centre-stage in clinical trials for HIV/AIDS drug: Nandita Vijayasimha, Bengaluru Saturday, November 30, 2024, 08:00 Hrs [IST] India has taken centre-stage in clinical ...
DGTR reviews PUC/PCN methodology for acrylonitrile butadiene rubber investigation: Shardul Nautiyal, Mumbai Saturday, November 30, 2024, 08:00 Hrs [IST] In order to define the sco ...
Kane Biotech Inc. announces that BioStem Technologies Inc. (BioStem), has recently signed a Letter of Intent to acquire commercial stage products and development technologies from the company’s ...